Form 4 for CLB Core Laboratories Inc. /DE/
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-01 · accession 0000950170-24-112230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-03 | 2024-10-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | +700 | 11.6K | +6% | $0 |
| D | 2024-10-03 | 2024-10-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | F - Tax | $19.21 | -276 | 11.3K | -2% | -$5,302 |
| D | 2024-10-03 | 2024-10-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | -700 | 2,850 | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-01 | M | A | 700 | $0.00 | 11,571.62 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-01 | F | D | 276 | $19.21 | 11,295.62 | D | — | — | |
| 3 | Derivative | Restricted Shares | 2024-10-01 | M | D | 700 | $0.00 | 2,850 | D | — · — to — | 700 Common Stock | (F2) Multiple restricted share grants are included in this total. (F1) The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. |